AJR Am J Roentgenol
- LI L, Burgio MD, Fetzer DT, Ferraioli G, et al
Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Diagnosis-AJR Expert
Panel Narrative Review.
AJR Am J Roentgenol. 2025 May 28. doi: 10.2214/AJR.25.32813.
Am J Pathol
- ZHONG H, Liu C, Huang Z, Tan P, et al
Crosstalk between Hepatic Stellate Cells and Hepatic Macrophages in Metabolic
Dysfunction-Associated Steatohepatitis.
Am J Pathol. 2025;195:1040-1056.
Biochem Biophys Res Commun
- CHEN C, Zhang M, Ma XH, Wang CM, et al
Hepatic stellate cell-derived Delta-like 1 is dispensable for injury-induced
liver fibrosis.
Biochem Biophys Res Commun. 2025;771:152011.
- ZHAO Y, Xie L, Liu B, Deng Y, et al
Novel insight into the role of Src family kinases in hepatocellular carcinoma and
therapeutic potential.
Biochem Biophys Res Commun. 2025;772:151970.
- SHI Q, Ren L, Papineau K, Yang X, et al
Pexidartinib impairs liver mitochondrial functions causing cell death in primary
human hepatocytes at clinically relevant concentrations.
Biochem Biophys Res Commun. 2025;773:152075.
- KOGA T, Hiromura M, Song Y, Zhao S, et al
Selenium binding protein 1 (SBP1) suppresses fructose-induced metabolic
dysfunction-associated steatotic liver disease.
Biochem Biophys Res Commun. 2025;770:152013.
BMC Cancer
- LIU J, Zhang T, Gao Y, Ji D, et al
Causal role of immune cells in primary liver cancer: a mendelian randomization
study.
BMC Cancer. 2025;25:928.
- ZHANG X, Huang XT, Xie JZ, Fu AQ, et al
Prognostic significance of the number of hepatic lesions in multifocal
intrahepatic cholangiocarcinoma after radical resection: an IPTW propensity-score
analysis.
BMC Cancer. 2025;25:930.
- MU Z, Su J, Yi J, Fan R, et al
A non-invasive nomogram for the prediction of poor prognosis of hepatocellular
carcinoma based on the novel marker Interleukin-41.
BMC Cancer. 2025;25:941.
- GENG D, Lv N, Miao Y
Pyogenic liver abscess following biliary stent placement in pancreatic cancer
patients: a retrospective case series.
BMC Cancer. 2025;25:965.
BMC Gastroenterol
- ZHANG M, Yuan Y, Wang C, Huang Y, et al
Aggregate index of systemic inflammation tied to increased fatty liver disease
risk: insights from NHANES data.
BMC Gastroenterol. 2025;25:399.
- HUANG Z, Ling W, Lyu G, Xu S, et al
Correlation analyses of ultrasonographic and histopathological characteristics of
porta hepatis lymph nodes in biliary atresia.
BMC Gastroenterol. 2025;25:398.
- XIANG Y, Mao W
Neutrophil-derived ratios as predictors of short-term mortality in HBV-associated
decompensated cirrhosis.
BMC Gastroenterol. 2025;25:404.
- LV M, Shafagh G, Yu S
Effect of synbiotics on the cardiovascular risk factors in patients with
non-alcoholic fatty liver: a GRADE assessed systematic review and meta-analysis.
BMC Gastroenterol. 2025;25:407.
- DENG L, Sun J, Wang J, Duan X, et al
Comprehensive analysis of risk factors and nomogram development for predicting
hepatic metastasis following radical resection of adenocarcinoma of the
esophagogastric junction.
BMC Gastroenterol. 2025;25:409.
- WANG J, He W, Cai X, Hu Z, et al
Relative fat mass and risk of metabolic dysfunction associated steatotic liver
disease and severe hepatic steatosis in U.S. adults: analysis of NHANES 2017-2020
data.
BMC Gastroenterol. 2025;25:410.
Br J Surg
- BARTHOLOMA WC, Gilg S, Lundberg P, Larsen PN, et al
Magnetic resonance-derived hepatic uptake index improves the identification of
patients at risk of severe post-hepatectomy liver failure.
Br J Surg. 2025;112:znaf103.
Dig Dis
- LIU JK, Chien N, Chong C, Barnett S, et al
Projected Tumor Characteristics and Survival of Patients with Nonviral
Hepatocellular Carcinoma in the United States.
Dig Dis. 2025 May 28:1-20. doi: 10.1159/000546600.
Endoscopy
- MURABAYASHI T, Sugimoto S
Troubleshooting for perforation due to proximal metal stent displacement in
endoscopic ultrasound-guided hepaticogastrostomy.
Endoscopy. 2025;57.
- NAGASHIMA K, Inaba Y, Kashima K, Kunogi Y, et al
Endoscopic injection sclerotherapy with ligation for esophageal varices using
single-use endoscope: Report of a video case.
Endoscopy. 2025;57.
Eur Radiol
- OCAL O, Zech CJ, Bali MA, Pasquier D, et al
Imaging in staging, treatment planning, and monitoring of hepatocellular
carcinoma for local and locoregional therapies: consensus recommendations from
EORTC and ESGAR.
Eur Radiol. 2025 May 23. doi: 10.1007/s00330-025-11699.
Gastroenterology
- MCGETTIGAN B, Hernandez-Tejero M, Malhi H, Shah V, et al
Immune Dysfunction and Infection Risk in Advanced Liver Disease.
Gastroenterology. 2025;168:1085-1100.
J Gastroenterol
- DING H, Lv H, Sui M, Wang X, et al
Interaction of neuropilin-1 and hepatocyte growth factor/C-Met pathway in liver
fibrosis progression in hepatocyte-specific NRP-1 knockout mice.
J Gastroenterol. 2025 May 26. doi: 10.1007/s00535-025-02262.
J Hepatol
- CHEW V
Harnessing spatial immunity to predict recurrence in hepatocellular carcinoma.
J Hepatol. 2025 May 27:S0168-8278(25)00239-9. doi: 10.1016/j.jhep.2025.
- ENGELMANN C
Rethinking hepatic encephalopathy: Gut microbes, neurotoxins and the therapeutic
horizon.
J Hepatol. 2025 May 27:S0168-8278(25)00295-8. doi: 10.1016/j.jhep.2025.
- ZHANG X, Shen J, Man K, Chu ESH, et al
Corrigendum to "CXCL10 plays a key role as an inflammatory mediator and a
non-invasive biomarker of non-alcoholic steatohepatitis" [J Hepatol (2014)
61:1365-75].
J Hepatol. 2025 May 24:S0168-8278(25)00157-6. doi: 10.1016/j.jhep.2025.
- RUDLER M
Autologous macrophage therapy for compensated cirrhosis, some hope at the
horizon.
J Hepatol. 2025 May 23:S0168-8278(25)00248-X. doi: 10.1016/j.jhep.2025.
- HIRSCH TZ
Immune exclusion in hepatoblastoma: is beta-catenin to blame again?
J Hepatol. 2025 May 21:S0168-8278(25)02203-2. doi: 10.1016/j.jhep.2025.
Oncogene
- GENG X, Li M, Zhang L, Cai Y, et al
P5CS deacetylation mediated by SIRT2 facilitates tumor growth by enhancing
mitochondrial respiration in hepatocellular carcinoma.
Oncogene. 2025 May 27. doi: 10.1038/s41388-025-03456.
PLoS One
- ESSAM MYN, Kouam AF, Fepa AGK, Seukep AJ, et al
Serological evidence and factors associated to liver damage in malaria-typhoid
infected patients consulting in two health facilities, Yaounde-Cameroon.
PLoS One. 2025;20:e0319547.
- WEI W, Gan Y, Zhang X, Chen Y, et al
Exploring the level of metabolic reprogramming and the role of prognostic factor
SF3A3 in hepatocellular carcinoma through integrated single-cell landscape
analysis.
PLoS One. 2025;20:e0323559.
- SCHACHTSCHNEIDER KM, Redlon LN, Lokken RP, Huang YH, et al
Epigenetic regulation of individual components of combined
hepatocellular-cholangiocarcinoma.
PLoS One. 2025;20:e0324145.
- BEI X, Zhao C, Liu J, Cao J, et al
PCYT2 overexpression induces mitochondrial damage and promotes apoptosis in
hepatocellular carcinoma cells.
PLoS One. 2025;20:e0323974.
- LU H, Mao Z, Zheng M, Zhang M, et al
Identification of hub gene for the pathogenic mechanism and diagnosis of MASLD by
enhanced bioinformatics analysis and machine learning.
PLoS One. 2025;20:e0324972.
- MA J, Xu R, Li R, Fu Y, et al
Integration of bioinformatics and identification of the role of m6A genes in
NAFLD.
PLoS One. 2025;20:e0321757.
- ZHAO K, Hu HT, Li HL, Cheng HT, et al
Analysis of the efficacy of splenic artery superselective embolization in
cirrhosis with hepatocellular carcinoma.
PLoS One. 2025;20:e0323829.
- JIANG H, Qin C, Xu YM
Feasibility of shear wave elastography for assessing steatosis in early-stage
non-alcoholic fatty liver disease.
PLoS One. 2025;20:e0324637.
- LU Y, Lin J, Lu Y, Lin L, et al
Hepatotoxicity of ICI monotherapy or combination therapy in HCC: A systematic
review and meta-analysis.
PLoS One. 2025;20:e0323023.
- HE Y, Chang Y, Liu X, Li Y, et al
Associations of flavonoid intakes with metabolic dysfunction-associated steatotic
liver disease in US adults.
PLoS One. 2025;20:e0322797.
Transplant Proc
- SINAN EFE Y, Ahmet A, Ebru T, Tolga S, et al
Echinococcal Liver Infections: Comparing Transplant Strategies for Granulosus and
Alveolaris.
Transplant Proc. 2025;57:916-921.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016